Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P48436: Variant p.Phe154Leu

Transcription factor SOX-9
Gene: SOX9
Feedback?
Variant information Variant position: help 154 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Phenylalanine (F) to Leucine (L) at position 154 (F154L, p.Phe154Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (F) to medium size and hydrophobic (L) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In CMD1; 5% of wild-type DNA binding activity; transcriptional activation is only reduced to 26% of wild-type activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 154 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 509 The length of the canonical sequence.
Location on the sequence: help ELSKTLGKLWRLLNESEKRP F VEEAERLRVQHKKDHPDYKY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         ELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKY

                              ELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKY

Rhesus macaque                ELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKY

Chimpanzee                    ELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKY

Mouse                         ELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKY

Rat                           ELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKY

Pig                           ELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKY

Chicken                       ELSKTLGKLWRLLNESEKRPFVEEAERLRVQHKKDHPDYKY

Xenopus tropicalis            ELSKTLGKLWRLLNEGEKRPFVEEAERLRIQHKKDHPDYKY

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 509 Transcription factor SOX-9
DNA binding 105 – 173 HMG box
Helix 148 – 168



Literature citations
Compound effects of point mutations causing campomelic dysplasia/autosomal sex reversal upon SOX9 structure, nuclear transport, DNA binding, and transcriptional activation.
Preiss S.; Argentaro A.; Clayton A.; John A.; Jans D.A.; Ogata T.; Nagai T.; Barroso I.; Schafer A.J.; Harley V.R.;
J. Biol. Chem. 276:27864-27872(2001)
Cited for: VARIANTS CMD1 LEU-154 AND THR-158; CHARACTERIZATION OF VARIANTS CMD1 LEU-154 AND THR-158;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.